FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

December - Emulsion PCR for highly sensitive detection
of tumour mutations in peripheral blood

The BEAMing technology involves conversion of single DNA molecules to single magnetic beads, each containing thousands of copies of the sequence of the original DNA molecule. The number of variant DNA molecules in the population can be assessed by staining the beads with fluorescent probes and counting them by using flow cytometry. This way OncoBEAM® blood-based tests deliver a minimally invasive alternative for sensitive real-time molecular diagnostics to improve cancer characterisation and treatment.

Scientific Calendar 2017

Oncology Overview

Go back to the overview of Oncology

Click Here

Blood-based molecular testing (OncoBEAM™)

Growing your knowledge
Visit our Academy
Grow your knowledge
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
Company movie
See our collection
See our collection
Grow your knowledge http://www.sysmex.no/academy.html
See our collection
See our library of smears http://www.sysmex.no/academy/library/image-gallery.html
Learn more about our concept http://www.sysmex.no/company/who-is-sysmex/silent-design.html